Amarin Corp PLC (AMRN)
0.9129
+0.08
(+9.99%)
USD |
NASDAQ |
May 02, 16:00
0.9129
0.00 (0.00%)
After-Hours: 20:00
Amarin Accounts Payable (Quarterly): 52.76M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 52.76M |
September 30, 2023 | 53.36M |
June 30, 2023 | 54.31M |
March 31, 2023 | 58.78M |
December 31, 2022 | 64.60M |
September 30, 2022 | 93.16M |
June 30, 2022 | 116.31M |
March 31, 2022 | 90.75M |
December 31, 2021 | 114.92M |
September 30, 2021 | 72.42M |
June 30, 2021 | 141.25M |
March 31, 2021 | 94.26M |
December 31, 2020 | 105.88M |
September 30, 2020 | 121.37M |
June 30, 2020 | 86.76M |
March 31, 2020 | 98.33M |
December 31, 2019 | 49.95M |
September 30, 2019 | 42.04M |
June 30, 2019 | 34.02M |
March 31, 2019 | 26.78M |
December 31, 2018 | 37.63M |
September 30, 2018 | 26.17M |
June 30, 2018 | 34.47M |
March 31, 2018 | 31.88M |
December 31, 2017 | 25.16M |
Date | Value |
---|---|
September 30, 2017 | 15.80M |
June 30, 2017 | 16.46M |
March 31, 2017 | 15.12M |
December 31, 2016 | 6.062M |
September 30, 2016 | 6.864M |
June 30, 2016 | 14.81M |
March 31, 2016 | 15.14M |
December 31, 2015 | 10.83M |
September 30, 2015 | 17.90M |
June 30, 2015 | 13.01M |
March 31, 2015 | 10.76M |
December 31, 2014 | 8.525M |
September 30, 2014 | 6.059M |
June 30, 2014 | 5.543M |
March 31, 2014 | 4.823M |
December 31, 2013 | 6.375M |
September 30, 2013 | 6.233M |
June 30, 2013 | 9.688M |
March 31, 2013 | 22.94M |
December 31, 2012 | 17.46M |
September 30, 2012 | 13.70M |
June 30, 2012 | 8.429M |
March 31, 2012 | 4.568M |
December 31, 2011 | 4.419M |
September 30, 2011 | 3.836M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
34.02M
Minimum
Jun 2019
141.25M
Maximum
Jun 2021
81.33M
Average
86.76M
Median
Jun 2020
Accounts Payable (Quarterly) Benchmarks
Trinity Biotech PLC | 14.50M |
DBV Technologies SA | 23.30M |
Adaptimmune Therapeutics PLC | 8.128M |
Akari Therapeutics PLC | 1.671M |
Biodexa Pharmaceuticals Plc | 0.40M |